Colgate-Palmolive Company $CL Stock: Maryland State Retirement & Pension System Grows Stake

Maryland State Retirement & Pension System boosted its holdings in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 13.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 48,672 shares of the company’s stock after purchasing an additional 5,756 shares during the period. Maryland State Retirement & Pension System’s holdings in Colgate-Palmolive were worth $4,153,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Corient Private Wealth LP grew its holdings in shares of Colgate-Palmolive by 29.0% in the 2nd quarter. Corient Private Wealth LP now owns 639,604 shares of the company’s stock worth $58,639,000 after acquiring an additional 143,812 shares during the last quarter. Bank of America Corp DE purchased a new stake in shares of Colgate-Palmolive during the second quarter valued at $567,483,000. Brandywine Financial Group lifted its holdings in shares of Colgate-Palmolive by 35,612.3% during the first quarter. Brandywine Financial Group now owns 72,853 shares of the company’s stock valued at $6,209,000 after purchasing an additional 72,649 shares during the last quarter. Cohen Klingenstein LLC lifted its holdings in shares of Colgate-Palmolive by 9.0% during the third quarter. Cohen Klingenstein LLC now owns 167,669 shares of the company’s stock valued at $14,306,000 after purchasing an additional 13,870 shares during the last quarter. Finally, SEB Asset Management AB acquired a new position in shares of Colgate-Palmolive in the 1st quarter valued at $91,149,000. 80.41% of the stock is currently owned by institutional investors.

Key Colgate-Palmolive News

These are some of the CL news items that stood out recently:

  • Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $3.91 from $3.85, close to the $3.92 consensus, and nudged its FY2027 and FY2028 forecasts higher to $4.06 and $4.38, respectively. These revisions suggest modest confidence in longer-term earnings growth. Zacks Research Has Bullish Forecast for CL FY2026 Earnings
  • Neutral Sentiment: The analyst revisions were not uniformly positive: Zacks also lowered several quarterly estimates, including Q1 and Q2 FY2027 and Q1 and Q2 FY2028, while increasing others. The overall picture is therefore mixed rather than a broad-based upgrade. Zacks Research forecast coverage
  • Negative Sentiment: A Colgate-Palmolive executive vice president sold $401,677 worth of company shares. Insider sales can weigh on sentiment, although a single transaction does not necessarily indicate a change in the company’s outlook. Insider Selling: Colgate-Palmolive EVP Sells Stock

Insiders Place Their Bets

In other Colgate-Palmolive news, insider John Hazlin sold 23,376 shares of the firm’s stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $99.15, for a total transaction of $2,317,730.40. Following the completion of the sale, the insider directly owned 27,021 shares in the company, valued at approximately $2,679,132.15. This trade represents a 46.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Gregory Malcolm sold 4,100 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $97.97, for a total value of $401,677.00. Following the transaction, the executive vice president directly owned 10,061 shares in the company, valued at approximately $985,676.17. This trade represents a 28.95% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 77,414 shares of company stock valued at $7,613,786 over the last ninety days. Corporate insiders own 0.43% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on CL shares. Deutsche Bank reissued a “buy” rating and issued a $101.00 price target (up from $99.00) on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Evercore boosted their price objective on Colgate-Palmolive from $100.00 to $101.00 and gave the stock an “outperform” rating in a report on Thursday, October 8th. JPMorgan Chase & Co. reduced their price objective on shares of Colgate-Palmolive from $104.00 to $102.00 and set an “overweight” rating for the company in a research note on Monday, November 2nd. Morgan Stanley raised their target price on shares of Colgate-Palmolive from $104.00 to $111.00 and gave the stock an “overweight” rating in a report on Monday, November 2nd. Finally, Jefferies Financial Group reiterated a “hold” rating and issued a $89.00 target price (up from $88.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Thirteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $101.22.

Read Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $99.62 on Monday. The company’s fifty day moving average is $90.94 and its two-hundred day moving average is $90.29. The company has a quick ratio of 0.63, a current ratio of 0.96 and a debt-to-equity ratio of 11.23. Colgate-Palmolive Company has a 12-month low of $75.96 and a 12-month high of $101.18. The company has a market cap of $79.19 billion, a P/E ratio of 39.07, a price-to-earnings-growth ratio of 4.51 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, October 30th. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.93 by $0.04. The company had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.34 billion. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.91 earnings per share. Equities analysts expect that Colgate-Palmolive Company will post 3.92 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 13th. Investors of record on Tuesday, October 20th were given a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend was Tuesday, October 20th. Colgate-Palmolive’s payout ratio is presently 83.14%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.